World News Insights
1-3 Minute Gist

Browse Articles or use Lyrarc's US patented "Groups" and "Links" for new insights. A Lyrarc Group of Articles on a topic gives insights into particular angles shown in the Group Title. A Lyrarc Link shows more specific insights for 2 articles.

Xi Jinping Tariff Negotiating Strategy with US Articles

LyrArc brings in selected articles from many of the world's top publications.

Articles are selected by experts and you can see the gist of the important articles.


Wall Street Journal Original article ›
LyrArc Article Gist
The US share of Japanese exporting companies went down from 20% to 16% in the 2007-2010 period, while the exports from Japan to China, India, and Brazil have gone up by 25% in the same period. Korean companies like Hyundai and Samsung plunged early into the Indian market. LG and Samsung have a significant share in the electronics and consumer appliance markets in India. By comparison Sony's share is about 5% according to Euromonitor research. Now Japanese compaies are putting a new focus on India. In food products Nissin is expanding aggressively by doubling its noodle making capacity, and making its Ramen brand available in smaller packages costing 10 cents each. The idea is to customize the effort to the unique nature of the Indian market.
Wall Street Journal Original article ›
Wall Street Journal Original article ›
New York Times Original article ›
LyrArc Article Gist
Coca Cola's minority stake in Honest Tea, and the issue of the words "no high fructose corn syrup" on the label for the Honest Kids product. The insistence of Honest Tea founders to keep the label in negotiations with Coke.
New York Times Original article ›
New York Times Original article ›
New York Times Original article ›
LyrArc Article Gist
Chrysler plans to set up separate showrooms and separate employees for the Fiat 500 at about 210 sales outlets.
New York Times Original article ›
LyrArc Article Gist
The Indian pharmaceutical industry is expected to grow by 13% to $24 billion in 2010. R&D is a special focus, as new drugs can be developed at much lower cost in India. Mr. Piramal, for instance, kept the R&D operation of Piramal when he sold the rest of the company to Abbott Labs of the USA. The Piramal lab in Mumbai has 300 researchers and scientists, and Mr Piramal says he can develop new drugs at a tenth of the $1.5- $2 billon cost it takes for this in the USA and Europe.
New York Times Original article ›
Wall Street Journal Original article ›
New York Times Original article ›
New York Times Original article ›
New York Times Original article ›
Economist Original article ›
Economist Original article ›
Economist Original article ›
LyrArc Article Gist
Global austerity measures could lead to a weaker and slower recovery in the absence of other policy actions to tackle the deficits in the medium term.
New York Times Original article ›
Wall Street Journal Original article ›
Wall Street Journal Original article ›
Wall Street Journal Original article ›
Wall Street Journal Original article ›
Wall Street Journal Original article ›
New York Times Original article ›
New York Times Original article ›
Wall Street Journal Original article ›

Support LyrArc

We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.

Support Lyrarc from as small as $1


Copyright © 2006 - 2026 Intelilinks LLC
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us